Skip to main content
Clinical Trials/NCT05641051
NCT05641051CompletedPhase 4

Effects of Metoclopramide Administration on Gastric Emptying in Mechanically Ventilated Critically Ill Patients : A Prospective Randomized Controlled Trial

Tanta University1 site in 1 country80 target enrollmentStarted: December 14, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
80
Locations
1
Primary Endpoint
Assessment of the risk of aspiration

Study Overview

Brief Summary

The aim of this study is to evaluate the prokinetic effect of metoclopramide on gastric emptying in critically ill mechanically ventilated patients .

Detailed Description

More than 50% of patients in ICU have gastric dysmotility, which leads to slow gastric emptying(GE) and high gastric residual volume (GRV) and is associated with increased mortality in these patients

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Masking Description

The drugs will be prepared by a dedicated anesthesiologist who is aware of the allocated group and will have no subsequent role in the study.

Eligibility Criteria

Ages
20 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients' age 20 - 60 years.
  • Either gender.
  • Mechanically ventilated head trauma patients.
  • Patients receiving enteral feeding via nasogastric tube.

Exclusion Criteria

  • Patients with contraindications to enteral feeding.
  • Patients with extrapyramidal manifestations.
  • Patients with known allergy to metoclopramide.
  • Patients with seizures.
  • Patients with renal or hepatic diseases.

Arms & Interventions

Metoclopramide group

Experimental

Patients will receive 10 mg intravenous metoclopramide / 6 hours.

Intervention: Metoclopramide (Drug)

Control group

Placebo Comparator

Patients will receive the same volume of intravenous placebo / 6 hours.

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Assessment of the risk of aspiration

Time Frame: 8 hours interval during first 5 days of enteral feeding

Aspiration risk will be categorized using the system proposed by Ven de Putte and Perlas. As: * patients with empty antrum and gastric residual volume \< 1.5 mL/kg: low risk. * patients with solid contents or gastric residual volume \> 1.5 mL/kg: high risk.

Secondary Outcomes

  • Incidence of ventilator associated pneumonia(8 hours interval during first 5 days of enteral feeding)
  • Time of weaning from mechanical ventilation(From the start of enteral feeding till intensive care discharge through study completion, an average of 6months)
  • Hospital stay(From the start of enteral feeding till intensive care discharge through study completion, an average of 6months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Khadija Mohammed Elbaradei

Resident of Anesthesia, Surgical Intensive Care and Pain Medicine

Tanta University

Study Sites (1)

Loading locations...

Similar Trials